Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI032424-05A2
Application #
2067304
Study Section
Special Emphasis Panel (ZRG5-ARRA (01))
Project Start
1991-09-30
Project End
1999-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016

  Publications

Chien Jr, Peter C; Cohen, Sandra; Kleeberger, Cynthia et al. (2002) High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression. J Infect Dis 186:205-13
Zhang, Peng Fei; Bouma, Peter; Park, Eun Ju et al. (2002) A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response. J Virol 76:644-55
Jeffs, S A; Gorny, M K; Williams, C et al. (2001) Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120. Immunol Lett 79:209-13
York, J; Follis, K E; Trahey, M et al. (2001) Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. J Virol 75:2741-52
Verrier, F; Nadas, A; Gorny, M K et al. (2001) Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6. J Virol 75:9177-86
Hioe, C E; Chien Jr, P C; Lu, C et al. (2001) LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol 75:1077-82
Taniguchi, Y; Zolla-Pazner, S; Xu, Y et al. (2000) Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41. Virology 273:333-40
Hioe, C E; Jones, G J; Rees, A D et al. (2000) Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120. AIDS Res Hum Retroviruses 16:893-905
Hochleitner, E O; Gorny, M K; Zolla-Pazner, S et al. (2000) Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A. J Immunol 164:4156-61
Park, E J; Gorny, M K; Zolla-Pazner, S et al. (2000) A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex. J Virol 74:4183-91

Showing the most recent 10 out of 57 publications